Stock comparison
Merck & Co., Inc. is 1.0x more valuable than Novartis AG by market capitalization ($308.78 B vs $294.66 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRK is larger
Merck & Co., Inc. is 1.0x more valuable than Novartis AG by market capitalization ($308.78 B vs $294.66 B).
Market value leader
MRK
Merck & Co., Inc. is 1.0x more valuable than Novartis AG by market capitalization ($308.78 B vs $294.66 B).
| Metric | MRK | NVS |
|---|---|---|
| Market cap | $308.78 B | $294.66 B |
| US-listed rank | #45 | #46 |
| Revenue (latest FY) | $65.01B | - |
| Net income (latest FY) | $18.25B | - |
| Net margin | 28.1% | - |
| P/E (trailing FY) | 16.9x | - |
| SEC filings | 998 | 981 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Merck & Co., Inc. is 1.0x more valuable than Novartis AG by market capitalization ($308.78 B vs $294.66 B).
Full pages: Merck & Co., Inc. and Novartis AG, or browse the full rankings.